BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23055556)

  • 1. The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq.
    Stik G; Dambrine G; Pfeffer S; Rasschaert D
    J Virol; 2013 Jan; 87(1):80-93. PubMed ID: 23055556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
    Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
    Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains.
    Zhang Y; Liu C; Yan F; Liu A; Cheng Y; Li Z; Sun G; Lv H; Wang X
    Vaccine; 2017 Aug; 35(36):4695-4701. PubMed ID: 28754487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus.
    Brown AC; Smith LP; Kgosana L; Baigent SJ; Nair V; Allday MJ
    J Virol; 2009 Nov; 83(21):11142-51. PubMed ID: 19692466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marek's disease: Genetic regulation of gallid herpesvirus 2 infection and latency.
    Gennart I; Coupeau D; Pejaković S; Laurent S; Rasschaert D; Muylkens B
    Vet J; 2015 Sep; 205(3):339-48. PubMed ID: 26067852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both homo and heterodimers of Marek's disease virus encoded Meq protein contribute to transformation of lymphocytes in chickens.
    Suchodolski PF; Izumiya Y; Lupiani B; Ajithdoss DK; Lee LF; Kung HJ; Reddy SM
    Virology; 2010 Apr; 399(2):312-21. PubMed ID: 20137800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style.
    Liu JL; Kung HJ
    Virus Genes; 2000; 21(1-2):51-64. PubMed ID: 11022789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic expression analysis of the cluster mdv1-mir-M9-M4, genes meq and vIL-8 differs between the lytic and latent phases of Marek's disease virus infection.
    Coupeau D; Dambrine G; Rasschaert D
    J Gen Virol; 2012 Jul; 93(Pt 7):1519-1529. PubMed ID: 22442112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene.
    Conradie AM; Bertzbach LD; Bhandari N; Parcells M; Kaufer BB
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.
    Kumar S; Kunec D; Buza JJ; Chiang HI; Zhou H; Subramaniam S; Pendarvis K; Cheng HH; Burgess SC
    BMC Syst Biol; 2012 Sep; 6():123. PubMed ID: 22979947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.
    Lian L; Qu L; Chen Y; Lamont SJ; Yang N
    PLoS One; 2012; 7(11):e51003. PubMed ID: 23226446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative roles as oncogene or tumour suppressor of the Mid-clustered microRNAs in Gallid alphaherpesvirus 2 (GaHV2) induced Marek's disease lymphomagenesis.
    Teng M; Yu ZH; Zhao P; Zhuang GQ; Wu ZX; Dang L; Li HZ; Ma SM; Cui ZZ; Zhang GP; Wu R; Luo J
    J Gen Virol; 2017 May; 98(5):1097-1112. PubMed ID: 28510513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperediting by ADAR1 of a new herpesvirus lncRNA during the lytic phase of the oncogenic Marek's disease virus.
    Figueroa T; Boumart I; Coupeau D; Rasschaert D
    J Gen Virol; 2016 Nov; 97(11):2973-2988. PubMed ID: 27655063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo expression patterns of microRNAs of Gallid herpesvirus 2 (GaHV-2) during the virus life cycle and development of Marek's disease lymphomas.
    Zhao P; Li XJ; Teng M; Dang L; Yu ZH; Chi JQ; Su JW; Zhang GP; Luo J
    Virus Genes; 2015 Apr; 50(2):245-52. PubMed ID: 25666057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marek's disease virus Meq oncoprotein interacts with chicken HDAC 1 and 2 and mediates their degradation via proteasome dependent pathway.
    Liao Y; Lupiani B; Izumiya Y; Reddy SM
    Sci Rep; 2021 Jan; 11(1):637. PubMed ID: 33437016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-encoded miR-155 ortholog is an important potential regulator but not essential for the development of lymphomas induced by very virulent Marek's disease virus.
    Yu ZH; Teng M; Sun AJ; Yu LL; Hu B; Qu LH; Ding K; Cheng XC; Liu JX; Cui ZZ; Zhang GP; Luo J
    Virology; 2014 Jan; 448():55-64. PubMed ID: 24314636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marek's disease viruses circulating in commercial poultry in Italy in the years 2015-2018 are closely related by their meq gene phylogeny.
    Mescolini G; Lupini C; Davidson I; Massi P; Tosi G; Catelli E
    Transbound Emerg Dis; 2020 Jan; 67(1):98-107. PubMed ID: 31411371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and pathogenicity characterization of Gallid herpesvirus 2 newly isolated in China from 2009 to 2013.
    Zhang YP; Lv HC; Bao KY; Gao YL; Gao HL; le Qi X; Cui HY; Wang YQ; Li K; Gao L; Wang XM; Liu CJ
    Virus Genes; 2016 Feb; 52(1):51-60. PubMed ID: 26611441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of a Marek's disease virus strain detected in tumour-bearing turkeys.
    Mescolini G; Lupini C; Davidson I; Massi P; Tosi G; Fiorentini L; Catelli E
    Avian Pathol; 2020 Apr; 49(2):202-207. PubMed ID: 31702386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of the meq gene of Marek's disease viruses detected in unvaccinated backyard chickens reveals the circulation of low- and high-virulence strains.
    Mescolini G; Lupini C; Felice V; Guerrini A; Silveira F; Cecchinato M; Catelli E
    Poult Sci; 2019 Aug; 98(8):3130-3137. PubMed ID: 30850833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.